Our Partnerships
Our partners are valued contributors in our global family of innovation. We are interested in partnering with organizations in the discovery, development, and commercialization of novel therapies within psychiatry and neurology. These collaborations enable us to maximize value for our patients, customers, and to support better health care.
Our Partnership Alliances
Our Partnership Alliances
with Affiliates
Our partnership with our Sumitomo Pharma Co., Ltd. affiliates strengthens our commitment to improving the lives of people around the globe. Sunovion is also affiliated with Sumitomo Pharma’s Frontier Business unit, a health care technology unit, that is dedicated to creating pioneering solutions that go beyond medication, providing more holistic support with a primary focus on active aging and mental health. By leveraging innovative technologies, we can deliver promising new medicines to patients in various therapeutic areas, sooner.
Sunovion’s collaboration with Urovant Sciences supports the commercialization of GEMTESA® (vibegron) tablets, an investigational medicine for the treatment of overactive bladder.
We are excited to work closely with our partners to launch Orgovyx™ (relugolix), a treatment for men with advanced prostate cancer.
